Digital Therapeutics Startup Cara Care Raised $7 Million To Fuel Expansion - Upsmag - Magazine News

Digital Therapeutics Startup Cara Care Raised $7 Million To Fuel Expansion

Cara Care, a digital therapeutics startup focused on gastrointestinal health issues, has raised $7 million in a Series A Extension round, as the Berlin, Germany-based company looks to scale up its app for irritable bowel syndrome and move into the US and other European European markets.

Dr. Schär AG, a family-owned international food and nutrition company that manufactures products for people with celiac and chronic kidney disease, led the round alongside existing investors Sabadell Asabys and Johnson & Johnson. Cara Care has raised $16 million to date.

The company also appointed Jim Mapes as CEO. Mapes has served in executive roles at a range of US-based healthcare companies, including Centauri Health Solutions, UnitedHealth Group’s Optum division and health insurer Anthem. Jesaja Brinkmann, 30, and Andre Sommer, 34, who co-founded the company in 2016, will serve as managing directors. Brinkmann is an alumnus of the 2021 forbes 30 Under 30 Healthcare and Science list

“The Dr. Schär family has been working for 100 years to serve people with special dietary needs to live better lives,” Philipp Schoeller, CEO of Dr. Schär AG, said in a statement. “In Cara Care, we have found a partner who can make this mission even more successful with the help of the most innovative technologies. We are extremely excited about working with the team and Jim Mapes as an excellent addition to the management.”

When a patient signs up for the Cara Care app, they input their symptoms to get a personalized program to help manage their condition. This includes one-on-one coaching and dietary, mental health and exercise interventions.

Brinkmann says the app is close to having 1 million users who use it to help with a range of conditions, including irritable bowel syndrome, inflammatory bowel disease and acid reflux. . He says the majority of users come organically from Google and the Apple App Store where Cara Care has 4.8 stars. “We have been on the market for quite some time now, for around six years and we have built up a good reputation,” says Brinkmann.

Healthcare professionals also recommend the app to patients. In Germany, the 12-week Cara Care app program is reimbursed by health insurance. “One of our core principles is to work on the foundation of evidence-based medicine, which means that we are constantly evaluating the efficiency of the interventions and solutions that we are delivering to our patients,” says Brinkmann.

The funding will allow Cara Care to scale up commercialization of its app, expand to other European countries and also grow the company footprint by adding a team in the United States.

“There is an opportunity to build patients in digital health, to empower with digestive issues, to guide them through the different interventions that are possible and finally make them healthier. Which in the end, is our company mission,” says Sommer.

Cara Care, a digital therapeutics startup focused on gastrointestinal health issues, has raised $7 million in a Series A Extension round, as the Berlin, Germany-based company looks to scale up its app for irritable bowel syndrome and move into the US and other European European markets.

Dr. Schär AG, a family-owned international food and nutrition company that manufactures products for people with celiac and chronic kidney disease, led the round alongside existing investors Sabadell Asabys and Johnson & Johnson. Cara Care has raised $16 million to date.

The company also appointed Jim Mapes as CEO. Mapes has served in executive roles at a range of US-based healthcare companies, including Centauri Health Solutions, UnitedHealth Group’s Optum division and health insurer Anthem. Jesaja Brinkmann, 30, and Andre Sommer, 34, who co-founded the company in 2016, will serve as managing directors. Brinkmann is an alumnus of the 2021 forbes 30 Under 30 Healthcare and Science list

“The Dr. Schär family has been working for 100 years to serve people with special dietary needs to live better lives,” Philipp Schoeller, CEO of Dr. Schär AG, said in a statement. “In Cara Care, we have found a partner who can make this mission even more successful with the help of the most innovative technologies. We are extremely excited about working with the team and Jim Mapes as an excellent addition to the management.”

When a patient signs up for the Cara Care app, they input their symptoms to get a personalized program to help manage their condition. This includes one-on-one coaching and dietary, mental health and exercise interventions.

Brinkmann says the app is close to having 1 million users who use it to help with a range of conditions, including irritable bowel syndrome, inflammatory bowel disease and acid reflux. . He says the majority of users come organically from Google and the Apple App Store where Cara Care has 4.8 stars. “We have been on the market for quite some time now, for around six years and we have built up a good reputation,” says Brinkmann.

Healthcare professionals also recommend the app to patients. In Germany, the 12-week Cara Care app program is reimbursed by health insurance. “One of our core principles is to work on the foundation of evidence-based medicine, which means that we are constantly evaluating the efficiency of the interventions and solutions that we are delivering to our patients,” says Brinkmann.

The funding will allow Cara Care to scale up commercialization of its app, expand to other European countries and also grow the company footprint by adding a team in the United States.

“There is an opportunity to build patients in digital health, to empower with digestive issues, to guide them through the different interventions that are possible and finally make them healthier. Which in the end, is our company mission,” says Sommer.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Quick Telecast is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.
Click to rate this post!
[Total: 0 Average: 0]
Leave a Comment

GIPHY App Key not set. Please check settings